Literature DB >> 9077627

Bacterial vaginosis and intraamniotic infection.

E R Newton1, J Piper, W Peairs.   

Abstract

OBJECTIVE: We sought to determine the predictors of intraamniotic infection with use of the presence or absence of vaginal microbes and clinical variables. STUDY
DESIGN: Vaginal fluid was collected and analyzed on 936 of 2711 (35%) consecutive patients who were delivered over a 7-month period. Subjects were followed up prospectively for the development of intraamniotic infection. Intraamniotic infection was defined as an intrapartum fever > 37.8 degrees C plus at least two of the five following variables: maternal or fetal tachycardia, leukocytosis, tender uterus, or foul-smelling amniotic fluid. Bacterial vaginosis score and the presence or absence of aerobic vaginal organisms were independent microbial variables. Demographic, maternal, labor, and delivery characteristics were independent clinical variables. Stepwise logistic regression analysis was used to develop adjusted odds ratios for predicting intraamniotic infection (expressed as odds ratio [95% confidence interval]). Selection bias and microbiologic reliability were measured.
RESULTS: A bacterial vaginosis score of 7 to 10 (odds ratio 1.7, [95% confidence interval 1.0 to 3.9]), nulliparity (2.1 [1.3 to 3.4]), each hour of internal fetal electrode (1.2 [1.0-1.3]); and, each vaginal examination (1.7 [1.0-3.9]) were predictors of intraamniotic infection. Selected aerobic vaginal organisms such as group B streptococci or gram-negative rods were not predictive. Reanalysis with a bacterial vaginosis score > or = 4 revealed similar predictors of intraamniotic infection. Bacterial vaginosis had an adjusted odds ratio of 1.85 (1.16 to 2.9). Selected higher risk populations, vaginal examinations > or = 6 (n = 365), or rupture of membranes > or = 7 hours (n = 421) did not change the risk of a bacterial vaginosis score > or = 4 (adjusted odds ratio 1.87 and 1.98, respectively).
CONCLUSION: Abnormal vaginal flora combines with clinical variables to increase the risk of intraamniotic infection.

Entities:  

Mesh:

Year:  1997        PMID: 9077627     DOI: 10.1016/s0002-9378(97)70568-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

2.  Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

Authors:  Katia Sutyak Noll; Patrick J Sinko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

3.  Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Richard D Ludescher; Alla A Aroutcheva; Sebastian Faro; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2009-01-20       Impact factor: 4.609

4.  Maternal stress is associated with bacterial vaginosis in human pregnancy.

Authors:  J F Culhane; V Rauh; K F McCollum; V K Hogan; K Agnew; P D Wadhwa
Journal:  Matern Child Health J       Date:  2001-06

Review 5.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

6.  Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections.

Authors:  L Gibney; M Macaluso; K Kirk; M S Hassan; J Schwebke; S H Vermund; P Choudhury
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

7.  The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

Authors:  Katia Sutyak Noll; Mark N Prichard; Arkady Khaykin; Patrick J Sinko; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 8.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

9.  A population-based study of the risk of repeat clinical chorioamnionitis in Washington State, 1989-2008.

Authors:  Hannah N Cohen-Cline; Talia R Kahn; Carolyn M Hutter
Journal:  Am J Obstet Gynecol       Date:  2012-08-17       Impact factor: 8.661

10.  Acquisition of iron by Gardnerella vaginalis.

Authors:  G P Jarosik; C B Land; P Duhon; R Chandler; T Mercer
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.